Collaborating for effective genomic surveillance of

SARS-CoV-2 variants

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus eget egestas urna. Mauris pulvinar leo nec dui lobortis, a dictum dolor gravida. Aliquam maximus ante at bibendum vehicula. Vestibulum pellentesque, augue a sagittis tristique, ante mauris facilisis odio, sed pellentesque magna.

Quisque quis neque eget libero semper mattis ut non quam. Quisque vestibulum, velit vel interdum laoreet, risus ipsum bibendum massa, vitae aliquet nisl turpis nec diam. Sed suscipit malesuada lorem. Curabitur lectus dui, luctus sed varius at, cursus id nibh. Pellentesque vel urna vel lorem laoreet blandit et eu purus. Duis sed maximus nunc. Donec eu mauris diam.

Show less

Abstract

Get a behind-the-scenes look at how Dr. Richard Michelmore, Director of the Genome Center at UC Davis, set up a PCR-based testing workflow for SARS-CoV-2 in 6 weeks and is now leading an exemplary genomic surveillance programme for emerging variants of concern. This panel discussion reveals lessons learned on the essential feedback loop with LGC, Biosearch Technologies to ensure variant detection panels remain accurate.

Topics covered

  1. Lessons learned from setting up a high-throughput PCR-based SARS-CoV-2 testing centre.
  2. Clinical implications for monitoring emerging SARS-CoV-2 mutations and variants of concern.
  3. Cross-organisational collaboration in maintaining the accuracy of PCR-based detection panels for a robust genomic
    surveillance programme.

Speakers

Square_Richard_Michelmore_650x650

Dr. Richard Michelmore

Director, Genome Center,
UC Davis

Square_Tania_Nolan_650x650

Dr. Tania Nolan

Head of Assay Design and Development,

LGC Biosearch Technologies

Square_Lutz-Froenicke_650x650

Dr. Lutz Froenicke

Manager, DNA Technologies Core - Genome Center
UC Davis

Square_Lindy-McClelland_650x650

Dr. Lindy McClelland

Senior Scientist, Assay Design and Development Team
LGC, Biosearch Technologies

Additional resources

brand-document-icon-green
Variant characterisation
Learn more
document-teal
How do SARS-CoV-2 variants affect PCR assays for COVID-19 testing blog
Learn more
brand-document-icon-magenta
Keeping up with COVID: Designing novel monitoring assays to tackle the rise of variants editorial
Learn more
brand-document-icon-purple
Genomic surveillance: 3 techniques to detect and characterise SARS-CoV-2 variants blog
Learn more

Copyright © 2021 LGC, Biosearch Technologies